Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
46 hedge funds and large institutions have $168M invested in Decibel Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 19 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less funds holding
Funds holding: 54 → 46 (-8)
26% less capital invested
Capital invested by funds: $226M → $168M (-$58.2M)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.24M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.66M |
| 3 |
BCM
Bronte Capital Management
Bondi Junction,
Australia
|
+$1.41M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$635K |
| 5 |
Morgan Stanley
New York
|
+$600K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.93M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.27M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.93M |
| 4 |
State Street
Boston,
Massachusetts
|
-$661K |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$652K |
DBTX Hedge Fund Activity: Q2 2021 in Review
46 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q2 2021, worth a combined $168M — down 26% from $226M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of DBTX and 11 opened new positions — a net loss of 8 holders — while 17 trimmed existing stakes and 7 added.
The largest buyer was Credit Suisse, opening a new position worth an estimated $2.24M. The largest seller was BlackRock, cutting an estimated $2.93M.
- 46 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q2 2021, down from 54 in Q1 2021.
- Funds reported $168M of Decibel Therapeutics, Inc. Common Stock stock for Q2 2021, down 26% quarter-over-quarter.
- 11 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q2 2021 and 19 closed out, a net change of -8 holders.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q2 2021 was Credit Suisse, an estimated $2.24M added.
- The largest Decibel Therapeutics, Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $2.93M sold.
Based on aggregated 13F filings for Q2 2021.